{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T17:35:58Z","timestamp":1722965758418},"reference-count":22,"publisher":"Index Copernicus","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Otolaryngol Pol"],"published-print":{"date-parts":[[2022,1,21]]},"abstract":"<b>Introduction:<\/b> Studies on the pathophysiology of chronic rhinosinusitis have shown an effect of IgE antibodies on the course of the disease, as well as the effectiveness of treatment. Steroid therapy remains the most prevailing method of CRS treatment. <\/br><\/br> <b>Aim: <\/b>The aim of our study was to determine the clinical response to systemic and local steroid therapy in patients with CRSsNP depending on the total IgE antibody serum concentration. <\/br><\/br> <b>Material and methods:<\/b> A total of 92 patients with CRSsNP took part in the study, where they were divided randomly into 2 groups. In group I, the patients received fluticasone propionate 800 mcg\/day intranasally for 12 weeks. Patients in group II were treated with prednisone at a dose of 0.5 mg\/kg\/day, given orally, for 7 consecutive days and continued by another week with decreasing dosage. Both groups were evaluated prior to and following treatment using the TSS score of CRS clinical symptoms, the endoscopic Lund-Kennedy scale and the Lund-Mackay CT staging of chronic rhinosinusitis. Statistical analy-sis of the effectiveness of treatment was carried out in subgroups according to the total IgE serum concentrations obtained before treatment. <\/br><\/br> <b>Results:<\/b> Both groups of patients achieved statistically significant improvement in the TSS evaluation, as well as in endosco-pic and CT imaging findings. In patients with a total IgE serum concentration over 100 IU\/ml systemic steroid therapy sho-wed significantly greater effect on the relief of CRS symptoms in the TSS score than intranasal steroid therapy. Analogous differences in the effectiveness of both methods were not found in patients with a normal total IgE serum concentration (<100 IU\/ml). <\/br><\/br> <b>Conclusions:<\/b> A short course of systemic steroid therapy is more effective than local treatment in relieving of CRS symptoms in patients with CRSsNP with elevated serum concentration of IgE antibodies. Atopy may be considered a specific predictor of response to steroid therapy in the treatment of chronic rhinosinusitis.\n\n<\/jats:p>","DOI":"10.5604\/01.3001.0015.7082","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T10:21:30Z","timestamp":1654770090000},"page":"26-31","source":"Crossref","is-referenced-by-count":2,"title":["Atopy as a specific predictor of response to systemic and local steroid therapy in patients with chronic rhinosinusitis without nasal polyps"],"prefix":"10.5604","volume":"76","author":[{"given":"Wiktor","family":"Miechowski","sequence":"first","affiliation":[{"name":"Departments of Otolaryngology, Mazovian Hospital Brodnowski in Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Czerwaty","sequence":"additional","affiliation":[{"name":"Departments of Otolaryngology, Mazovian Hospital Brodnowski in Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izabella","family":"Godlewska","sequence":"additional","affiliation":[{"name":"Departments of Otolaryngology, Mazovian Hospital Brodnowski in Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"D\u017caman","sequence":"additional","affiliation":[{"name":"Departments of Otolaryngology, Mazovian Hospital Brodnowski in Warsaw, Poland; Department of Otolaryngology, Centre of Postgraduate Medical Education in Warsaw, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3689","reference":[{"key":"226753r1","unstructured":"Fokkens W.J., Lund V.J., Hopkins C. et al.: Europejskie wytyczne na temat zapalenia zatok przynosowych i polip\u00f3w nosa 2020. Otorynolaryngolo-gia, 2020; 75\u201376."},{"key":"226753r2","doi-asserted-by":"crossref","unstructured":"Lee K., Tai J., Lee S.H., Kim T.H.: Advances in the knowledge of the under-lying airway remodeling mechanisms in chronic rhinosinusitis based on the endotypes: a review. Int J Mol Sci., 2021; 22(2): 910.","DOI":"10.3390\/ijms22020910"},{"key":"226753r3","doi-asserted-by":"crossref","unstructured":"Kingler A., Stevens W.W., Tan B.K. et al.: Mechanisms and biomarkers of inflammatory endotypes in chronic rhinosinusitis without nasal polyps. J Allergy Clin Immunol., 2021; 147(4): 1306\u20131317.","DOI":"10.1016\/j.jaci.2020.11.037"},{"key":"226753r4","doi-asserted-by":"crossref","unstructured":"Staudacher A.G., Peters A.T., Kato A., Stevens W.W.: Use of endotypes, phe-notypes, and inflammatory markers to guide treatment decisions in chro-nic rhinosinusitis. Ann Allergy Asthma Immunol, 2020; 124(4): 318\u2013325.","DOI":"10.1016\/j.anai.2020.01.013"},{"key":"226753r5","doi-asserted-by":"crossref","unstructured":"Stevens W.W., Peters A.T., Tan B.K. et al.: Associations Between Inflam-matory Endotypes and Clinical Presentations in Chronic Rhinosinusitis. J Allergy Clin Immunol Pract, 2019; 7(8): 2812\u20132820 e3.","DOI":"10.1016\/j.jaip.2019.05.009"},{"key":"226753r6","doi-asserted-by":"crossref","unstructured":"Brown H., Tajudeen B.A., Hannah N Kuhar H.N. et al.: Defining the Aller-gic Endotype of Chronic Rhinosinusitis by Structured Histopathology and Clinical Variables. J Allergy Clin Immunol Pract., 2021; 9(10): 3797\u20133804.","DOI":"10.1016\/j.jaip.2021.06.013"},{"key":"226753r7","doi-asserted-by":"crossref","unstructured":"Ho J., Alvarado R., Rimmer J. et al.: Atopy in chronic rhinosinusitis: impact on quality of life outcomes. Int Forum Allergy Rhinol., 2019; 9(5): 501\u2013507.","DOI":"10.1002\/alr.22272"},{"key":"226753r8","doi-asserted-by":"crossref","unstructured":"de Borja Callejas F., Mart\u00ednez-Ant\u00f3n A., Picado C. et al.: Corticosteroid treatment regulates mucosal remodeling in chronic rhinosinusitis with na-sal polyps. Laryngoscope, 2015; 125(5): E158\u2013E167.","DOI":"10.1002\/lary.25147"},{"key":"226753r9","doi-asserted-by":"crossref","unstructured":"Fokkens W.J., Lund V.J., Hopkins C. et al.: Executive summary of EPOS 2020 including integrated care pathways. Rhinology, 2020; 58(2): 82\u2013111.","DOI":"10.4193\/Rhin20.601"},{"key":"226753r10","doi-asserted-by":"crossref","unstructured":"Zhou B., He G., Liang J. et al.: Mometasone furoate nasal spray in the tre-atment of nasal polyposis in Chinese patients: a double-blind, randomi-zed, placebo-controlled trial. Int Forum Allergy Rhinol, 2016; 6(1): 88\u201394.","DOI":"10.1002\/alr.21650"},{"key":"226753r11","doi-asserted-by":"crossref","unstructured":"Kirtsreesakul V., Wongsritrang K., Ruttanaphol S.: Does oral prednisolone increase the efficacy of subsequent nasal steroids in treating nasal polypo-sis? Am J Rhinol Allergy, 2012; 26(6): 455\u2013462.","DOI":"10.2500\/ajra.2012.26.3820"},{"key":"226753r12","doi-asserted-by":"crossref","unstructured":"Ecevit M.C., Erdag T.K., Dogan E., Sutay S.: Effect of steroids for nasal po-lyposis surgery: A placebo-controlled, randomized, double-blind study. Laryngoscope, 2015; 125(9): 2041\u20132045.","DOI":"10.1002\/lary.25352"},{"key":"226753r13","doi-asserted-by":"crossref","unstructured":"Wei C.C., Adappa N.D., Cohen N.A.: Use of topical nasal therapies in the ma-nagement of chronic rhinosinusitis. Laryngoscope, 2013; 123(10): 2347\u20132359.","DOI":"10.1002\/lary.24066"},{"key":"226753r14","doi-asserted-by":"crossref","unstructured":"Alobid I., Benitez P., Valero A. et al.: Oral and intranasal steroid treat-ments improve nasal patency and paradoxically increase nasal nitric oxide in patients with severe nasal polyposis. Rhinology, 2012; 50(2): 171\u2013177.","DOI":"10.4193\/Rhin10.140"},{"key":"226753r15","doi-asserted-by":"crossref","unstructured":"Vaidyanathan S., Barnes M., Williamson P. et al.: Combined oral and in-tranasal corticosteroid therapy for nasal polyps. Ann Intern Med, 2011; 155(4): 277\u2013278.","DOI":"10.7326\/0003-4819-155-4-201108160-00023"},{"key":"226753r16","doi-asserted-by":"crossref","unstructured":"Snidvongs K., Kalish L., Sacks R. et al.: Topical steroid for chronic rhinosi-nusitis without polyps. Cochrane Database Syst Rev, 2011; 10(8): CD009274.","DOI":"10.1002\/14651858.CD009274"},{"key":"226753r17","doi-asserted-by":"crossref","unstructured":"Chang M.T., Hwang P.H.: Challenging our assumptions: oral corticostero-ids and chronic rhinosinusitis without nasal polyposis. Int Forum Allergy Rhinol, 2021; 11(8): 1149\u20131151.","DOI":"10.1002\/alr.22817"},{"key":"226753r18","doi-asserted-by":"crossref","unstructured":"De Silva A.P., Schembri M.A., Sarah A.H. et al.: Short-term Oral Steroids Significantly Improves Chronic Rhinosinusitis Without Nasal Polyps. La-ryngoscope, 2021; 131(10): E2618\u2013E2626.","DOI":"10.1002\/lary.29495"},{"key":"226753r19","doi-asserted-by":"crossref","unstructured":"Toro M.D.C., Antonio M.A., Dos Reis M.G.A. et al.: Achieving the best me-thod to classify Eosinophilic Chronic Rhinosinusitis: a systematic review. Rhinology, 2021; 59(4): 330\u2013339.","DOI":"10.4193\/Rhin20.512"},{"key":"226753r20","doi-asserted-by":"crossref","unstructured":"Patel G.B., Kern R.C., Bernstein J.A. et al.: Current and Future Treatments of Rhinitis and Sinusitis. J Allergy Clin Immunol Pract, 2020; 8(5): 1522\u20131531.","DOI":"10.1016\/j.jaip.2020.01.031"},{"key":"226753r21","doi-asserted-by":"crossref","unstructured":"Fujieda S., Matsune S., Takeno S. et al.: Dupilumab efficacy in chronic rhi-nosinusitis with nasal polyps from SINUS-52 is unaffected by eosinophilic status. Allergy, 2022; 77(1): 186\u2013196.","DOI":"10.1111\/all.14906"},{"key":"226753r22","doi-asserted-by":"crossref","unstructured":"Gevaert P., Omachi T.A., Corren J. et al.: Efficacy and safety of omalizu-mab in nasal polyposis: 2 randomized phase 3 trials. J Allergy Clin Immu-nol, 2020; 146(3): 595\u2013605.","DOI":"10.1016\/j.jaci.2020.05.032"}],"container-title":["Otolaryngologia Polska"],"original-title":[],"link":[{"URL":"https:\/\/otolaryngologypl.com\/gicid\/pdf\/01.3001.0015.7082","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/otolaryngologypl.com\/gicid\/pdf\/01.3001.0015.7082","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T10:59:14Z","timestamp":1657191554000},"score":1,"resource":{"primary":{"URL":"https:\/\/otolaryngologypl.com\/gicid\/01.3001.0015.7082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,8]]}},"URL":"https:\/\/doi.org\/10.5604\/01.3001.0015.7082","relation":{},"ISSN":["0030-6657","2300-8423"],"issn-type":[{"value":"0030-6657","type":"print"},{"value":"2300-8423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,21]]}}}